Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy (BT) FOLFOX Chemotherapy for Stage II/III Rectal Cancer

NCT01659424 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.

NCT NCT01659424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01659424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy (BT) FOLFOX Chemotherapy for Stage II/III Rectal Cancer
Lead sponsor
Beth Israel Medical Center
Phase
Phase 2
Overall status
Withdrawn
Start date
June 30, 2011
Completion date
November 30, 2014
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer